Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2020 and Revises Upward Full Year 2020 Guidance
Go back to Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2020 and Revises Upward Full Year 2020 Guidance| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 8.23 +0.22 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.01 | 52 Week High | $44.38 | |||
| Open | $8.03 | 52 Week Low | $24.47 | |||
| Day High | $8.54 | P/E | 411.50 | |||
| Day Low | $8.03 | EPS | $0.02 | |||
| Volume | 549,661 | |||||
